View:
Download DOC
Download PDF
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Heine Lisa Wipperman
(Last) (First) (Middle)
9924 WEST 74TH STREET
(Street)
EDEN PRAIRIE MN 55344
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SURMODICS INC [ SRDX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2018 A 1,739 A $0.00 3,015(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $27.3 02/20/2018 A 5,275 (2) 02/20/2025 Common Stock 5,275 $0.00 5,275 D
Explanation of Responses:
1. The amount beneficially owned includes 3,015 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
2. The award will vest in full on February 20, 2019.
Remarks:
/s/ Bryan K. Phillips, on behalf of Lisa Wipperman Heine 02/22/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

	I, Lisa Wipperman Heine, hereby authorize and designate each of
 Bryan K. Phillips, Douglas P. Long, Nicole J. Leimer, and Amra Hoso signing
 singly, as my true and lawful attorney-in-fact to:

	(1)	execute for and on my behalf, in my capacity as an officer and/or director
of Surmodics, Inc., a Minnesota corporation (the "Company"), the  Forms 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act  of 1934 (the
"Exchange Act") and the rules and regulations promulgated thereunder;

	(2)	do and perform any and all acts for and on my behalf which may be necessary
or desirable to complete and execute any such Forms 4 or 5 and timely file such
form with the Securities and Exchange Commission, any stock exchange or similar
authority, and the NASDAQ Stock Market; and

	(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my benefit,
in my best interest, or legally required of me, it being understood that the
statements executed by such attorney-in-fact on my behalf pursuant to this Power
of Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-fact's discretion.

	I hereby further grant to each such attorney-in-fact full power and
 authority to do and perform any and every act and thing whatsoever requisite,
 necessary, or proper to be done in the exercise of any of the rights and
 powers herein granted, as fully to all intents and purposes as I might or
 could do if personally present, with full power of substitutes or revocation,
 hereby ratifying and confirming all that such attorney-in-fact, or such
 attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
 granted.  I hereby acknowledge that the foregoing attorneys-in-fact, in
 serving in such capacity at my request, are not assuming, nor is the Company
 assuming, any of my responsibilities to comply with Section 16 of the Exchange
 Act.

	This Power of Attorney shall remain in full force and effect until
 I am no longer required to file Forms 4 and 5 with respect to my holdings of
 and transactions in securities issued by the Company, unless earlier revoked
 by me in a signed writing delivered to the foregoing attorneys-in-fact.
  Notwithstanding the foregoing, if any such attorney-in-fact hereafter ceases
 to be either a partner or employee of Faegre Baker Daniels LLP, or an employee
of the Company, this Power of Attorney shall be automatically revoked solely as
to such individual, immediately upon such cessation, without any further action
on my part.

	I hereby revoke all previous Powers of Attorney that have been
 granted by me in connection with my reporting obligations under Section 16 of
 the Exchange Act with respect to my holdings of and transactions in securities
issued by the Company.

	IN WITNESS WHEREOF, I have caused this Power of Attorney to be duly
 executed as of this 14th day of April, 2017.

						/s/ Lisa Wipperman Heine